| Jordan Carlton Schramm, MD | |
|
1055 N 300 W Ste 401, Provo, UT 84604-3306 | |
| (801) 357-7499 | |
| (801) 373-5980 |
| Full Name | Jordan Carlton Schramm |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology - Pediatric Otolaryngology |
| Location | 1055 N 300 W Ste 401, Provo, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588976328 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 9712365-1205 (Utah) | Secondary |
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | 9712365-1205 (Utah) | Primary |
| Entity Name | Peak Ent Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346489036 PECOS PAC ID: 4284781543 Enrollment ID: O20090402000646 |
News Archive
"When stakeholders from across the world converge at Washington next month to participate in the International AIDS Conference (IAC) to share their experience and evaluations and to influence both popular and official perceptions and practices for curbing HIV/AIDS, India will host a parallel event for those who cannot make it there," the Hindu reports.
Researchers led by Dr. Soheil Dadras at the Stanford University Medical Center have developed a novel methodology to extract microRNAs from cancer tissues. The related report by Ma et al, "Profiling and discovery of novel miRNAs from formalin-fixed paraffin-embedded melanoma and nodal specimens," appears in the September 2009 issue of the Journal of Molecular Diagnostics.
Montreux Equity Partners, LLC, and GC Aesthetics, Ltd., today announced the completion of a US$30 million private equity investment by Montreux into GCAL. GCAL is a leading designer, manufacturer, and distributor of medical devices for the global aesthetics industry. Montreux entered into the financing agreement with GCAL to accelerate the company's expansion plans.
Several Kansas State University faculty members are helping children with auditory processing disorder receive better treatment.
Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of its Genesys HTA System for the treatment of menorrhagia. The Genesys HTA System is a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jordan Carlton Schramm, MD 1055 N 300 W Ste 401, Provo, UT 84604-3306 Ph: (801) 357-7499 | Jordan Carlton Schramm, MD 1055 N 300 W Ste 401, Provo, UT 84604-3306 Ph: (801) 357-7499 |
News Archive
"When stakeholders from across the world converge at Washington next month to participate in the International AIDS Conference (IAC) to share their experience and evaluations and to influence both popular and official perceptions and practices for curbing HIV/AIDS, India will host a parallel event for those who cannot make it there," the Hindu reports.
Researchers led by Dr. Soheil Dadras at the Stanford University Medical Center have developed a novel methodology to extract microRNAs from cancer tissues. The related report by Ma et al, "Profiling and discovery of novel miRNAs from formalin-fixed paraffin-embedded melanoma and nodal specimens," appears in the September 2009 issue of the Journal of Molecular Diagnostics.
Montreux Equity Partners, LLC, and GC Aesthetics, Ltd., today announced the completion of a US$30 million private equity investment by Montreux into GCAL. GCAL is a leading designer, manufacturer, and distributor of medical devices for the global aesthetics industry. Montreux entered into the financing agreement with GCAL to accelerate the company's expansion plans.
Several Kansas State University faculty members are helping children with auditory processing disorder receive better treatment.
Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of its Genesys HTA System for the treatment of menorrhagia. The Genesys HTA System is a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia.
› Verified 8 days ago
Dr. Phillip Lee Chaffin Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W, Ste 401, Provo, UT 84604 Phone: 801-357-7499 Fax: 801-373-5980 | |
Matthew K. Money, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1157 N 300 W, Suite 301, Provo, UT 84604 Phone: 801-357-4460 Fax: 801-357-4090 | |
Dr. Kipp Moreno Robins, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 500 W Bldg A, Provo, UT 84604 Phone: 801-812-5033 | |
Kirt Scott Beus, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W, Suite 401, Provo, UT 84604 Phone: 801-357-7499 Fax: 801-373-5980 | |
Scott Shipley, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W Ste 401, Provo, UT 84604 Phone: 801-357-7499 Fax: 801-373-5980 | |
Dr. Seth Allred Riddle, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W, Suite 401, Provo, UT 84604 Phone: 801-357-7499 Fax: 801-373-5980 |